← Back to Search

Other

Nutritional Supplements for Hip Fracture

Q: Would I be eligible to take part in this clinical trial?

This trial has an age restriction of 65 to 89 years old and is only eligible for individuals who have suffered a hip fracture. A maximum of 40 patients can take part in the study.

Q: Are adults over the age of 20 eligible to participate in this investigation?

This trial is exclusively looking for participants aged 65 to 89, and the total number of trials enrolling patients in this age range stands at 392. For individuals under 18 years old, 64 separate clinical trials are available.

Q: Are there any currently available vacancies for prospective participants in this research?

According to clinicaltrials.gov, the initial posting for this study was on August 1st 2023 and it has since been updated as of July 31st 2023. Unfortunately, recruitment is not currently underway but there are 384 other trials actively looking for participants at present time.

Phase < 1

Recruiting

Led By Boris Zelle, MD

Research Sponsored by The University of Texas Health Science Center at San Antonio

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 26 weeks

Awards & highlights

Study Summary

This trial tests a nutrition program to help elderly hip fracture patients stay healthy & active.

Who is the study for?

This trial is for men and women aged 65-89 who have a closed hip fracture needing surgery. They must be able to take pills, follow the study's drug schedule, and adhere to nutritional advice. It's not for those with open fractures, prisoners, certain surgical cases outside fixation or arthroplasty, allergies to the study drugs, or those who can't tolerate oral supplements.Check my eligibility

What is being tested?

The trial is testing a comprehensive nutrition plan using Juven and Centrum Silver 50+ in elderly patients with hip fractures. The goal is to see if this approach reduces their functional decline as well as morbidity (health complications) and mortality after surgery.See study design

What are the potential side effects?

Possible side effects from Juven and Centrum Silver may include digestive discomfort or allergic reactions in those sensitive to ingredients in these supplements. However, specific side effects will depend on individual tolerances.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 26 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 26 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 26 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Assessment of surgical complications at 26 weeks

Secondary outcome measures

Grip strength

Hospital Readmissions

Quality of Life Survey (Short-form 36 Health (SF-36))

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Nutritional SupplementsExperimental Treatment2 Interventions

Juven and Centrum Silver 50+ will be administered to this group

Group II: ControlActive Control1 Intervention

Standard of care procedures

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Juven

2010

Completed Phase 3

~910

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor

453 Previous Clinical Trials

91,390 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,845 Total Patients Enrolled

5 Trials studying Hip Fracture

655 Patients Enrolled for Hip Fracture

Boris Zelle, MDPrincipal InvestigatorUniversity of Texas Health Science Center San Antonio

Media Library

Comprehensive Nutritional Intervention (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05971173 — Phase < 1

Hip Fracture Research Study Groups: Nutritional Supplements, Control

Hip Fracture Clinical Trial 2023: Comprehensive Nutritional Intervention Highlights & Side Effects. Trial Name: NCT05971173 — Phase < 1

Comprehensive Nutritional Intervention (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05971173 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would I be eligible to take part in this clinical trial?

"This trial has an age restriction of 65 to 89 years old and is only eligible for individuals who have suffered a hip fracture. A maximum of 40 patients can take part in the study."

Answered by AI

Are adults over the age of 20 eligible to participate in this investigation?

"This trial is exclusively looking for participants aged 65 to 89, and the total number of trials enrolling patients in this age range stands at 392. For individuals under 18 years old, 64 separate clinical trials are available."

Answered by AI

Are there any currently available vacancies for prospective participants in this research?

"According to clinicaltrials.gov, the initial posting for this study was on August 1st 2023 and it has since been updated as of July 31st 2023. Unfortunately, recruitment is not currently underway but there are 384 other trials actively looking for participants at present time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery

Boris Zelle 2023. "Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05971173.